Annual report
6823.TEDINET S100R2I9
Period2022-04-01 → 2023-03-31
Filed2023-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥22.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥20.5bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.8bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥3.1bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.3bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.6bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.2bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.6bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.0bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥2.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥34.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥33.2bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥30.7bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥29.9bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥28.5bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.9bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.9bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥26.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥25.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥23.7bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥22.2bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥21.0bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.4bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.7bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.8bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.3bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥3.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥952m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥970m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥757m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥577m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥542m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥566m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥529m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥532m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥146.33 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.41 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥133.27 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.96 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥163.14 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,163.3 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,057.4 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,931.15 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,810.87 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,713.99 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 77.0% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.3% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.3% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.9% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.9% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.1% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.9% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 998 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 954 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 932 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 916 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 886 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥18.5bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥18.2bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥16.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥17.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥17.0bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.1bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥2.6bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.6bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.9bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.6bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.0bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.9bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.6bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥1.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.0bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥30.7bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥29.9bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥27.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥26.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥25.8bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥6.6bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥6.8bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥24.0bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥23.0bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥21.5bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥20.4bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥19.3bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥6.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥129.53 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.29 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.15 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137.39 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥159.05 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥45 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥43 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥43 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,954.68 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,872.33 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,750.31 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,659.3 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,569.38 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 78.4% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.1% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.0% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.9% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.7% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.8% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 12,319,100 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,309,100 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,303,400 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,294,400 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,294,400 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 495 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 504 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 502 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 501 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 496 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥154m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥60m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥8.4bn |
| Environmental Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥429m |
| Environmental Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥142m |
| Environmental Equipmentreportable segment | employees | at 2023-03-31 | 177 pure |
| Environmental Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Environmental Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Environmental Equipmentreportable segment | segment assets | at 2023-03-31 | ¥6.9bn |
| Environmental Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥300m |
| Medical Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥959m |
| Medical Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥315m |
| Medical Equipmentreportable segment | employees | at 2023-03-31 | 563 pure |
| Medical Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥12.2bn |
| Medical Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥12.2bn |
| Medical Equipmentreportable segment | segment assets | at 2023-03-31 | ¥11.5bn |
| Medical Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.0bn |
| Particle Countersreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥534m |
| Particle Countersreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥199m |
| Particle Countersreportable segment | employees | at 2023-03-31 | 146 pure |
| Particle Countersreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥6.6bn |
| Particle Countersreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥6.6bn |
| Particle Countersreportable segment | segment assets | at 2023-03-31 | ¥7.8bn |
| Particle Countersreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.5bn |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥656m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥23.9bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥23.9bn |
| —segment total | segment assets | at 2023-03-31 | ¥26.2bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥2.8bn |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥64m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥64m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥10.3bn |
| Environmental Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥238m |
| Environmental Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥141m |
| Environmental Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.7bn |
| Environmental Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.7bn |
| Environmental Equipmentreportable segment | segment assets | at 2022-03-31 | ¥5.1bn |
| Environmental Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥574m |
| Medical Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥501m |
| Medical Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥310m |
| Medical Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥11.7bn |
| Medical Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥11.7bn |
| Medical Equipmentreportable segment | segment assets | at 2022-03-31 | ¥10.9bn |
| Medical Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥806m |
| Particle Countersreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥245m |
| Particle Countersreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥190m |
| Particle Countersreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥6.3bn |
| Particle Countersreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥6.3bn |
| Particle Countersreportable segment | segment assets | at 2022-03-31 | ¥6.8bn |
| Particle Countersreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.7bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥984m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥641m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥22.6bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥22.6bn |
| —segment total | segment assets | at 2022-03-31 | ¥22.9bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥3.1bn |
| Environmental Equipmentreportable segment | employees | at 2023-03-31 | 123 pure |
| Medical Equipmentreportable segment | employees | at 2023-03-31 | 226 pure |
| Particle Countersreportable segment | employees | at 2023-03-31 | 93 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,572
| Item | Context | Value | Unit |
|---|---|---|---|
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.857 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 1.141 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 0.914 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.784 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 0.950 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.859 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.221 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.246 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.318 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | 563 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | 89 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 177 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 9 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01842-000ParticleCountersReportableSegmentMember | 146 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E01842-000ParticleCountersReportableSegmentMember | 7 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 112 | |
| Average number of temporary workers | CurrentYearInstant_CorporateSharedMember | 16 | |
| Number of employees | CurrentYearInstant | 998 | |
| Average number of temporary workers | CurrentYearInstant | 121 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 495 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 41.5 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 17.1 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 7686000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | 226 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 123 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01842-000ParticleCountersReportableSegmentMember | 93 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 53 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 495 | |
| Research and development expenses research and development activities | CurrentYearDuration | 1904000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | 938000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 588000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01842-000ParticleCountersReportableSegmentMember | 376000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | 958939000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 428551000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01842-000ParticleCountersReportableSegmentMember | 533814000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_CorporateSharedMember | 153723000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 2075029000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 12319100 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 12319100 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 12319100 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 12319100 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 18 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 26 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 81 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 86 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 9 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 5174 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 5394 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |